CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Preferred Stock	Treasury Stock	Additional Paid in Capital	Accumulated Deficit
Balance at beginning (in shares) at Dec. 31, 2023		75,879,025
Balance at beginning at Dec. 31, 2023	$ 57,025	$ 8	$ 0	$ (1,019)	$ 204,186	$ (146,150)
Balance at beginning (in shares) at Dec. 31, 2023			165,045
Changes in Stockholders' Equity
Net loss	(19,889)					(19,889)
Issuance of common stock upon vesting of restricted stock (in shares)		83,020
Issuance of common stock upon exercise of options (in shares)		84,649
Issuance of common stock upon exercise of options	73				73
Share-based compensation expense	4,087				4,087
Balance at ending (in shares) at Mar. 31, 2024		76,046,694
Balance at ending at Mar. 31, 2024	41,296	$ 8	$ 0	(1,019)	208,346	(166,039)
Balance at ending (in shares) at Mar. 31, 2024			165,045
Balance at beginning (in shares) at Dec. 31, 2023		75,879,025
Balance at beginning at Dec. 31, 2023	57,025	$ 8	$ 0	(1,019)	204,186	(146,150)
Balance at beginning (in shares) at Dec. 31, 2023			165,045
Changes in Stockholders' Equity
Net loss	(35,368)
Balance at ending (in shares) at Jun. 30, 2024		77,224,263
Balance at ending at Jun. 30, 2024	29,206	$ 8	$ 0	(1,019)	211,735	(181,518)
Balance at ending (in shares) at Jun. 30, 2024			165,045
Balance at beginning (in shares) at Mar. 31, 2024		76,046,694
Balance at beginning at Mar. 31, 2024	41,296	$ 8	$ 0	(1,019)	208,346	(166,039)
Balance at beginning (in shares) at Mar. 31, 2024			165,045
Changes in Stockholders' Equity
Net loss	(15,479)					(15,479)
Issuance of common stock upon vesting of restricted stock (in shares)		1,174,868
Issuance of common stock upon exercise of options (in shares)		2,701
Issuance of common stock upon exercise of options	2				2
Share-based compensation expense	3,387				3,387
Balance at ending (in shares) at Jun. 30, 2024		77,224,263
Balance at ending at Jun. 30, 2024	$ 29,206	$ 8	$ 0	(1,019)	211,735	(181,518)
Balance at ending (in shares) at Jun. 30, 2024			165,045
Balance at beginning (in shares) at Dec. 31, 2024	75,737,112	77,470,886
Balance at beginning at Dec. 31, 2024	$ 3,589	$ 8	$ 0	(1,019)	215,413	(210,813)
Balance at beginning (in shares) at Dec. 31, 2024	165,045		165,045
Changes in Stockholders' Equity
Net loss	$ (19,585)					(19,585)
Issuance of common stock upon vesting of restricted stock (in shares)		1,023,867
Issuance of common stock upon exercise of options (in shares)		160,537
Issuance of common stock upon exercise of options	137				137
Issuance of common stock upon private placement, net (in shares)		12,006,510
Issuance of common stock upon private placement, net	15,359	$ 1			15,358
Issuance of preferred stock upon exchange of debt for equity (in shares)			37,233
Issuance of preferred stock upon exchange of debt for equity	4,111				4,111
Share-based compensation expense	1,458				1,458
Balance at ending (in shares) at Mar. 31, 2025		90,661,800
Balance at ending at Mar. 31, 2025	$ 5,069	$ 9	$ 0	(1,019)	236,477	(230,398)
Balance at ending (in shares) at Mar. 31, 2025			202,278
Balance at beginning (in shares) at Dec. 31, 2024	75,737,112	77,470,886
Balance at beginning at Dec. 31, 2024	$ 3,589	$ 8	$ 0	(1,019)	215,413	(210,813)
Balance at beginning (in shares) at Dec. 31, 2024	165,045		165,045
Changes in Stockholders' Equity
Net loss	$ (36,594)
Balance at ending (in shares) at Jun. 30, 2025	93,279,822	95,013,596
Balance at ending at Jun. 30, 2025	$ (8,985)	$ 9	$ 0	(1,019)	239,432	(247,407)
Balance at ending (in shares) at Jun. 30, 2025	193,706		193,706
Balance at beginning (in shares) at Mar. 31, 2025		90,661,800
Balance at beginning at Mar. 31, 2025	$ 5,069	$ 9	$ 0	(1,019)	236,477	(230,398)
Balance at beginning (in shares) at Mar. 31, 2025			202,278
Changes in Stockholders' Equity
Net loss	(17,009)					(17,009)
Issuance of common stock upon vesting of restricted stock (in shares)		642,020
Issuance of common stock upon exercise of options (in shares)		2,484,480
Issuance of common stock upon exercise of options	2,203				2,203
Issuance of common stock upon exercise of warrants (in shares)		368,096
Conversion of preferred stock to common stock (in shares)		857,200	(8,572)
Share-based compensation expense	$ 752				752
Balance at ending (in shares) at Jun. 30, 2025	93,279,822	95,013,596
Balance at ending at Jun. 30, 2025	$ (8,985)	$ 9	$ 0	$ (1,019)	$ 239,432	$ (247,407)
Balance at ending (in shares) at Jun. 30, 2025	193,706		193,706